MedTrace Logo

Global Fenestrated Anaconda Clinical STudy

NCT03180996 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-12-24

No results posted yet for this study

Summary

This study is a prospective non-interventional, multi-centre study of the Vascutek Fenestrated Anaconda™ system, and is essentially a post-market study. The Vascutek Fenestrated Anaconda™ system is a custom made device used for the treatment of Abdominal Aortic Aneurysm.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

Vascutek Fenestrated Anaconda™ Custom AAA Stent Graft System

Fenestrated Endovascular Aortic Repair (FEVAR)

Sponsors & Collaborators

  • Vascutek Ltd.

    lead INDUSTRY

Principal Investigators

  • Clark J Zeebregts, MD, PhD, Prof · Universitair Medisch Centrum Groningen (UMCG), Netherlands

  • Michel MPJ Reijnen, MD, PhD, Prof · Rijnstate Hospital, Arnhem, Netherlands

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-11
Primary Completion
2022-03-31
Completion
2030-12-31

Countries

  • Australia
  • Austria
  • Canada
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03180996 on ClinicalTrials.gov